Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

39.76
Delayed Data
As of Feb 12
 +0.61 / +1.56%
Today’s Change
37.24
Today|||52-Week Range
49.08
-1.46%
Year-to-Date
GSK Special Dividend: GSK will begin trading ex-dividend on 02/17/16 with a $1.2516 special dividend payable to shareholders of record as of 02/19/16.

Today’s Trading

Previous close39.15
Today’s open38.95
Day’s range38.91 - 39.77
Volume3,815,847
Average volume (3 months)3,856,449
Market cap$95.3B
Dividend yield5.99%
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+10.02%
Earnings growth (next 5 years)+7.40%
Revenue growth (last year)-3.66%
P/E ratio9.8
Price/Sales2.70
Price/Book12.57

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.18+0.37%
BMYBristol-Myers Squibb+0.68+1.14%
SNYSanofi+0.61+1.59%
ABBVAbbVie+0.40+0.77%
Data as of 4:02pm ET, 02/12/2016

Financials

Next reporting dateApril 27, 2016
EPS forecast (this quarter)$0.59
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers